VERAFLOX DIN 02437392
Status: Marketed
Holder: ELANCO CANADA LIMITED
Health Canada record
| Active ingredient(s) | PRADOFLOXACIN 15 MG |
|---|
| Dosage form | Tablet |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 24-Aug-2015 |
|---|
| Current status date | 13-Sep-2022 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2022-08-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PRADOFLOXACIN
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02436744 | VERAFLOX | ELANCO CANADA LIMITED | Suspension | PRADOFLOXACIN 25 MG | Marketed |
| 02437406 | VERAFLOX | ELANCO CANADA LIMITED | Tablet | PRADOFLOXACIN 60 MG | Marketed |
| 02437414 | VERAFLOX | ELANCO CANADA LIMITED | Tablet | PRADOFLOXACIN 120 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 25098 | 2021-01-28 | New Drug Submission (NDS) | CHANGE IN PRODUCT OWNERSHIP |
| 16630 | 2015-02-24 | New Drug Submission (NDS) | |
Request a quote for VERAFLOX
How to read a Canadian DIN record